Search For "malignancies"
Appendiceal cancer gets its own preclinical model
Updated : 3 years, 3 months ago IST
Appendiceal cancer (malignancies of the appendix, a small tissue pouch that is part of the gastrointestinal tract) is very rare, occurring in perhaps one or two people per 1 million per year. Prognoses are mixed, with a 5-year survival rate of 67 to 97 per cent for low-grade tumours detected
Read More
Study suggests protein plays a key role in immunotherapy
Updated : 3 years, 4 months ago IST
The study found protein is crucial in helping malignancies avoid immune attacks. The "fragile X mental retardation protein" (FMRP) is a protein that controls a network of genes and cells in the tumor microenvironment that help the tumor "hidden" from immune cells.
Read More
Study finds common mechanism tumours use to suppress immune responses
Updated : 3 years, 4 months ago IST
A Ludwig Cancer Research study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumours from immune detection and destruction
Read More
Surat Hematology Centre - 1st Centre of Excellence for Hematology and Bone
Updated : 3 years, 4 months ago IST
New Delhi [India], November 17 (ANI/SRV): Surat Hematology Centre, a comprehensive diagnostic and treatment facility for Hematological malignancies and other blood disorders for both adults and children, has become the first centre of excellence in Hematology and Bone Marrow Transplant (BMT)
Read More
In a first-in-human trial, FLASH radiation therapy shows promise
Updated : 3 years, 5 months ago IST
San Antonio [US], October 24 (ANI): The first-in-human research on a small number of patients with bone cancer reveals that FLASH radiation therapy, which delivers therapeutic amounts of radiation in a fraction of a second, may hold promise as a potential treatment for difficult-to-kill mali
Read More
Study: Novel treatment effective for bladder cancer
Updated : 3 years, 5 months ago IST
Washington [US], October 8 (ANI): An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new study in mice. The drug is now being tested in a national clinical trial for pa
Read More
Researchers warn about rising cancer cases among adults under 50 years of
Updated : 3 years, 6 months ago IST
Boston (Massachusetts) [US], September 7 (ANI): In recent decades, an increasing number of people under the age of 50 are developing cancer. According to a study undertaken by Brigham and Women's Hospital researchers, the incidence of early-onset malignancies (those detected before the age o
Read More
Study finds adults with blood cancer respond to booster dose of COVID-19 v
Updated : 3 years, 8 months ago IST
Washington [US], July 11 (ANI): According to a recent study, less than half of patients with hematologic malignancies developed detectable antibodies after the initial COVID-19 vaccination, but 56 per cent of "nonresponders" developed antibodies after receiving a booster dose.
Read More
New drug target for blood cancer, potentially solid tumours identified dur
Updated : 4 years, 5 months ago IST
New York [US], October 8 (ANI): The findings of a new study by Mount Sinai and UC San Diego researchers, for the first time, have shown how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and
Read More
Blocking fat storage might offer new way to treat most lethal form of brai
Updated : 5 years, 8 months ago IST
Ohio [USA], July 20 (ANI): Glioblastoma is a lethal form of brain cancer that accumulates fats in lipid droplets and uses them as energy for rapid cell division. Blocking an enzyme that GBM cells use to form the lipid droplets might offer a new way to treat this deadly disease, according to
Read More
New 'safe' immunotherapy offers hope for cancer patients with HIV
Updated : 8 years, 4 months ago IST
Washington D.C. [USA], Nov 8 (ANI): A new category of immunotherapies, called checkpoint inhibitors, appears safe to use in patients with both advanced malignancies and HIV, according to a recent study.
Read More